- Roche is a Switzerland-based biotechnology company that discovers, develops, and provides diagnostic and pharmaceutical products and services for the healthcare sector.View competitors9,999$ < 1M
Thomas Schinecker
CEO
- AbbVie is an Illinois-based pharmaceutical company that develops and markets medicinal drugs for the treatment of diseases in fields such as neuroscience and oncology.View competitors9,999$ < 1M
Richard A. Gonzalez
Chairman & CEO
- Genentech is a California-based biotechnology firm that develops and commercializes medicines for the treatment of diseases such as oncology and neuroscience.View competitors9,999$ < 1M
Alexander Hardy
CEO
- BMS is a New York-based biopharmaceutical firm that develops and commercializes medicines for treating patients prevail over serious diseases.View competitors9,999$ < 1M
Giovanni Caforio
Chairman & CEO
- Gilead is a California-based biopharmaceutical company that develops and commercializes antiviral drugs for a wide range of diseases.View competitors9,999$ < 1M
Daniel O’Day
Chairman & CEO
- Amgen is a California-based multinational biopharmaceutical company that develops human therapeutics for the treatment of diseases including cancer and cardiovascular.View competitors9,999$ < 1M
Robert A. Bradway
Chairman & CEO
- Biogen is a Massachusetts-based biotechnology company that researches and develops novel therapies for the treatment of neurological diseases across the globe.View competitors9,999$ < 1M
Christopher A Viehbacher
President & CEO
- QIAGEN is a Germany-based biotechnology company that provides solutions such as molecular diagnostics and sample preparation for pharmaceutical research applications.View competitors9,999$ < 1M
Thierry Bernard
Managing Director & CEO
- Illumina is a California-based manufacturer and supplier of products such as sequencing systems and microarray scanners for sectors including biotech and healthcare.View competitors9,999$ < 1M
Francis DeSouza
President & CEO
- Foundation Medicine is a Massachusetts-based biotechnology company that provides genomic profiling assays and clinical trail matching solutions for oncology research centers.View competitors9,999$ < 1M
Brian Alexander
CEO
- Charles River is a Massachusetts-based company that provides preclinical and clinical lab services for the healthcare sector.View competitors9,999$ < 1M
James C. Foster
Chairman & CEO
- PPD is a North Carolina-based contract research organization that provides drug discovery and lifecycle management services to the pharmaceutical and healthcare sectors.View competitors9,999$ < 1M
David Simmons
Chairman & CEO
- Ardelyx is a California-based biopharmaceutical firm that develops and commercializes minimally-systemic therapeutics for the treatment of cardiorenal and gastrointestinal diseases.View competitors9,999$ < 1M
Michael Raab
President & CEO
- Celgene develops and commercializes novel therapies for the treatment of cancer and inflammatory diseases.View competitors9,999$ < 1M
- Taconic is a New York-based biotechnology company that offers genetically engineered mouse model breeding services for research applications.View competitors9,999$ < 1M
Nancy J Sandy
CEO
- Adaptive Biotechnologies develops sequencing assays that characterize the adaptive immune system for research and biopharmaceutical industry.View competitors9,999$ < 1M
Chad Robins
Chairman & CEO
- Guardant Health is a California-based precision oncology firm that provides services such as cancer screening, recurrence monitoring and analytics for the healthcare sector.View competitors9,999$ < 1M
Helmy Eltoukhy
Co-CEO
- Ancestry is a genealogy company that provides family history research, DNA testing and gene analytics services for individuals and businesses.View competitors9,999$ < 1M
Deborah Liu
CEO
- Lonza is a Switzerland-based CDMO that offers services such as process development and particle engineering for pharmaceutical, biotech and specialty ingredients markets.View competitors9,999$ < 1M
Pierre-Alain Ruffieux
CEO
- BioMarin is a biotechnology company that develops and commercializes therapeutics for the treatment of genetic diseases.View competitors9,999$ < 1M
Jean Jacques Bienaime
Chairman & CEO
- Ambry Genetics is a California-based biotechnology company that provides genetic testing solutions such as screening and diagnosis for hereditary cancer and epilepsy.View competitors9,999$ < 1M
Tom Schoenherr
CEO
- bluebird is a Massachusetts-based biotechnology company that discovers and develops gene therapies for the treatment of genetic diseases.View competitors9,999$ < 1M
Andrew Obenshain
CEO
- Akebia Therapeutics focuses on treatments for ischemia and vascular diseases.View competitors9,999$ < 1M
John P. Butler
President & CEO
- Luminex is a Texas-based biotechnology company that develops and commercializes molecular diagnostics and vaccine testing systems for the life science sector.View competitors9,999$ < 1M
Nachum Shamir
Chairman & CEO
- Moderna is a Massachusetts-based biotechnology company that researches and develops messenger mRNA therapeutics to treat diseases such as cardiovascular and auto-immune.View competitors9,999$ < 1M
Stephane Bancel
Founder & CEO
- Genzyme is a pharmaceutical company that develops and commercializes drugs for rare diseases and multiple sclerosis.View competitors9,999$ < 1M
- Shire is a biopharmaceutical company that develops therapeutics for rare diseases and also offers patient advocacy services.View competitors9,999$ < 1M
- Adaptimmune is an England-based biotechnology company that researches and develops T-cell receptors for the treatment of cancer and infectious diseases.View competitors9,999$ < 1M
Adrian Rawcliffe
CEO
- Alkermes is a biopharmaceutical company that researches, develops, and commercializes pharmaceutical medicines for central nervous system diseases.View competitors9,999$ < 1M
Richard Pops
Chairman & CEO
- Exact Sciences is a Wisconsin-based molecular diagnostics company that provides services such as early-stage cancer detection and treatment guidance for healthcare providers.View competitors9,999$ < 1M
Kevin T. Conroy
Chairman & CEO
- Acceleron is a Massachusetts-based biopharmaceutical company that develops and commercializes therapies for the treatment of pulmonary and hematologic diseases.View competitors9,999$ < 1M
Habib Dable
President & CEO
- Promega is a manufacturer of enzymes and other products for biotechnology and molecular biology with genomics, protein analysis and expression.View competitors9,999$ < 1M
William A. Linton
Chairman & CEO
- Seagen is a Washington-based biotechnology company that develops and commercializes therapies for the treatment of cancer.View competitors9,999$ < 1M
David R. Epstein
CEO
- Natera is a medical diagnostics company that provides preconception, prenatal genetic testing, and counseling services.View competitors9,999$ < 1M
Steve Chapman
CEO
- Regeneron is a biotechnology company that develops and commercializes medicines for the treatment of metabolic, inflammatory and infectious diseases.View competitors9,999$ < 1M
Leonard S. Schleifer
President & CEO
- Kite Pharma is a California-based biotechnology company that researches and develops cell-based immunotherapies for the treatment of cancer.View competitors9,999$ < 1M
- Aldevron is a North Dakota-based biotechnology company that manufactures plasmid DNA, proteins, enzymes, antibodies, and related biologicals for clinical applications.View competitors9,999$ < 1M
Kevin Ballinger
CEO
- Invitae is a California-based medical genetics company that develops and supplies genetic diagnostic kits for the healthcare industry.View competitors9,999$ < 1M
Kenneth D. Knight
CEO
- Allogene Therapeutics develops an allogeneic chimeric antigen receptor for the treatment of cancer.View competitors9,999$ < 1M
David Chang
President & CEO
- Alnylam is a biopharmaceutical company that develops RNA interference therapeutics for genetically defined diseases.View competitors9,999$ < 1M
John Maraganore
CEO
- Evotec is a Germany-based drug discovery company that researches and develops RNA-targeting small molecules for the treatment of cancer and diabetes.View competitors9,999$ < 1M
Werner Lanthaler
CEO
- Affymetrix provides life science and molecular diagnostic products that enable parallel analysis of biological systems.View competitors9,999$ < 1M
- Blueprint Medicines is a Massachusetts-based biotechnology company that develops and commercializes precision therapies for the treatment of cancer.View competitors9,999$ < 1M
Kate Haviland
CEO
- Myriad is an Utah-based healthcare company that discovers and commercializes molecular diagnostic tests and equipments for inherited diseases.View competitors9,999$ < 1M
Paul J. Diaz
President & CEO
- Agenus is a biotechnology company that researches and develops novel antibodies and vaccines for the treatment of cancer.View competitors9,999$ < 1M
Garo H. Armen
Chairman & CEO
- Cellectis is a France-based biopharmaceutical company that researches and develops T-cell immunotherapies for the treatment of cancer.View competitors9,999$ < 1M
Andre Choulika
CEO
- Miltenyi Biotec is a Germany-based biotechnology company that research and developed therasorb therapeutic apheresis and preclinical imaging solutions for the medical sector.View competitors9,999$ < 1M
Boris Stoffel
Managing Director & CEO
- TC Biopharm is a Scotland-based biotechnology company that researches and develops CAR-T cell therapeutics for the treatment of cancer.View competitors9,999$ < 1M
Bryan Kobel
CEO
- BioMerieux is a France-based biotechnology company that develops and commercializes diagnosis systems for medical applications.View competitors9,999$ < 1M
Alexandre Merieux
Chairman & CEO
